Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-05 | Dr. van Es-Johansson has served on our Board since January 1, 2020... Dr. van Es-Johansson received a M.D. from Erasmus University, Rotterdam, The Netherlands. We believe Dr. van Es-Johansson brings extensive medical knowledge and experience in the pharmaceutical industry to our Board. |
| 2022-04-07 | Dr. van Es-Johansson has an M.D. and experience in pharmaceutical companies; no technical or software skills indicated. |
| 2023-03-07 | Dr. van Es-Johansson has an M.D. and has held executive roles in pharmaceutical companies; no mention of software or technical skills. |
| 2024-07-10 | Dr. van Es-Johansson received a M.D. from Erasmus University, Rotterdam, The Netherlands. We believe Dr. van Es-Johansson’s qualifications to serve on our Board include her extensive medical knowledge and experience in the pharmaceutical industry. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22